130 related articles for article (PubMed ID: 6943149)
1. Small bowel enterocyte abnormalities caused by methotrexate treatment in acute lymphoblastic leukaemia of childhood.
Gwavava NJ; Pinkerton CR; Glasgow JF; Sloan JM; Bridges JM
J Clin Pathol; 1981 Jul; 34(7):790-5. PubMed ID: 6943149
[TBL] [Abstract][Full Text] [Related]
2. Jejunal crypt cell abnormalities associated with methotrexate treatment in children with acute lymphoblastic leukaemia.
Pinkerton CR; Cameron CH; Sloan JM; Glasgow JF; Gwevava NJ
J Clin Pathol; 1982 Nov; 35(11):1272-7. PubMed ID: 6958682
[TBL] [Abstract][Full Text] [Related]
3. Methotrexate-induced malabsorption in children with acute lymphoblastic leukaemia.
Craft AW; Kay H; Lawson DN; McElwain TJ
Br Med J; 1977 Dec; 2(6101):1511-2. PubMed ID: 271033
[TBL] [Abstract][Full Text] [Related]
4. Oral methotrexate is as effective as intramuscular in maintenance therapy of acute lymphoblastic leukaemia.
Chessells JM; Leiper AD; Tiedemann K; Hardisty RM; Richards S
Arch Dis Child; 1987 Feb; 62(2):172-6. PubMed ID: 3469936
[TBL] [Abstract][Full Text] [Related]
5. Treatment of acute lymphoblastic leukaemia. Comparison of immunotherapy (B.C.G.), intermittent methotrexate, and no therapy after a five-month intensive cytotoxic regimen ((Concord trial). Preliminary report to the Medical Research Council by the Leukaemia Committee and the Working Party on Leukaemia in Childhood.
Br Med J; 1971 Oct; 4(5781):189-94. PubMed ID: 4940157
[TBL] [Abstract][Full Text] [Related]
6. Enterotoxic effect of methotrexate: does it influence the drug's absorption in children with acute lymphoblastic leukaemia?
Pinkerton CR; Glasgow JF; Bridges JM; Welshman SG
Br Med J (Clin Res Ed); 1981 Apr; 282(6272):1276-7. PubMed ID: 6784815
[No Abstract] [Full Text] [Related]
7. Intractable diarrhoea associated with continuation of cytotoxic chemotherapy during acute infective enteritis.
Pinkerton CR; Glasgow JF; Dempsey SI
Eur J Pediatr; 1983 Mar; 140(1):68-70. PubMed ID: 6575914
[TBL] [Abstract][Full Text] [Related]
8. Enteropathy complicating maintenance therapy in acute lymphoblastic leukaemia.
Lewis IJ; Mainwaring D; Martin J
Arch Dis Child; 1982 Sep; 57(9):663-7. PubMed ID: 6982027
[TBL] [Abstract][Full Text] [Related]
9. Reversal of severe methotrexate-induced intestinal damage using enteral n-3 fatty acids.
Koppelmann T; Pollak Y; Mogilner J; Bejar J; Coran AG; Sukhotnik I
Br J Nutr; 2013 Jan; 109(1):89-98. PubMed ID: 22456439
[TBL] [Abstract][Full Text] [Related]
10. Absorption of methotrexate under standardized conditions in children with acute lymphoblastic leukaemia.
Pinkerton CR; Welshman SG; Dempsey SI; Bridges JM; Glasgow JF
Br J Cancer; 1980 Oct; 42(4):613-5. PubMed ID: 6934003
[No Abstract] [Full Text] [Related]
11. Analysis of treatment in childhood leukaemia. I. Predisposition to methotrexate-induced neutropenia after craniospinal irradiation. Report to the Medical Research Council of the Working Party on Leukaemia in Childhood.
Br Med J; 1975 Sep; 3(5983):563-6. PubMed ID: 1100179
[TBL] [Abstract][Full Text] [Related]
12. Intermediate dose methotrexate (IDM) in childhood acute lymphocytic leukaemia in Norway. Report on a national treatment program.
Moe PJ; Seip M; Finne PH
Haematologia (Budap); 1981; 14(3):257-63. PubMed ID: 6948760
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of oral and intramuscular methotrexate in children with acute lymphoblastic leukaemia.
Pearson AD; Mills S; Amineddine HA; Long DR; Craft AW; Chessells JM
Cancer Chemother Pharmacol; 1987; 20(3):243-7. PubMed ID: 3315283
[TBL] [Abstract][Full Text] [Related]
14. Methotrexate infusions in poor prognosis acute lymphoblastic leukemia: II. High-dose methotrexate (HDM) in acute lymphoblastic leukemia in childhood: a pilot study from April 1981.
Moe PJ; Wesenberg F; Kolmannskog S
Med Pediatr Oncol; 1986; 14(3):189-90. PubMed ID: 3462466
[TBL] [Abstract][Full Text] [Related]
15. Functional and structural changes of the human proximal small intestine after cytotoxic therapy.
Cunningham D; Morgan RJ; Mills PR; Nelson LM; Toner PG; Soukop M; McArdle CS; Russell RI
J Clin Pathol; 1985 Mar; 38(3):265-70. PubMed ID: 3919064
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-alpha stimulates enterocyte proliferation and accelerates intestinal recovery following methotrexate-induced intestinal mucositis in a rat and a cell culture model.
Sukhotnik I; Shteinberg D; Ben Lulu S; Bashenko Y; Mogilner JG; Ure BM; Shaoul R; Shamian B; Coran AG
Pediatr Surg Int; 2008 Dec; 24(12):1303-11. PubMed ID: 18956197
[TBL] [Abstract][Full Text] [Related]
17. Treatment of acute lymphoblastic leukemia in childreq with "prophylactic" intrathecal methotrexate and intensive systemic chemotherapy.
Haghbin M; Tan CT; Clarkson BD; Miké V; Burchenal JH; Murphy ML
Cancer Res; 1975 Mar; 35(3):807-11. PubMed ID: 1054287
[TBL] [Abstract][Full Text] [Related]
18. Prophylactic central nervous system therapy with cranial irradiation and intrathecal methotrexate in acute lymphoblastic leukemia of childhood.
Wehinger H; Slanina J; Jacobi H; Musshoff K; Dietz V; Sauer M; Dilger M
Strahlentherapie; 1974 Dec; 148(6):590-8. PubMed ID: 4532340
[No Abstract] [Full Text] [Related]
19. Small bowel function in acute lymphoblastic leukaemia.
Pearson AD; Craft AW; Pledger JV; Eastham EJ; Laker MF; Pearson GL
Arch Dis Child; 1984 May; 59(5):460-5. PubMed ID: 6428327
[TBL] [Abstract][Full Text] [Related]
20. Refractory acute leukaemia in adults treated with sequential colaspase and high-dose methotrexate.
Yap BS; McCredie KB; Benjamin RS; Bodey GP; Freireich EJ
Br Med J; 1978 Sep; 2(6140):791-3. PubMed ID: 279387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
